ASH Submits Comments to FDA Re MRD and Complete Response in Multiple Myeloma

American Society of Hematology. (2026).
ASH Submits Comments to FDA Re MRD and Complete Response in Multiple Myeloma.
Retrieved from https://www.hematology.org/advocacy/testimony-and-correspondence/ash-submits-comments-to-fda-re-mrd-and-complete-response-in-multiple-myeloma.

American Society of Hematology.
"ASH Submits Comments to FDA Re MRD and Complete Response in Multiple Myeloma." Hematology.org.
https://www.hematology.org/advocacy/testimony-and-correspondence/ash-submits-comments-to-fda-re-mrd-and-complete-response-in-multiple-myeloma
(label-accessed April 10, 2026).

"American Society of Hematology."
ASH Submits Comments to FDA Re MRD and Complete Response in Multiple Myeloma, 10 Apr. 2026 ,
https://www.hematology.org/advocacy/testimony-and-correspondence/ash-submits-comments-to-fda-re-mrd-and-complete-response-in-multiple-myeloma.

Citation Manager Formats

• BibLaTeX
• Bookends
• EasyBib
• EndNote
• Mendeley
• Papers
• RIS
• Ref Manager
• RefWorks
• Zotero